PD-1TPD-1

Kongcheng Wang1,2, Jie Shao1,2, Kai Xin1,2

  • 1Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

Frontiers in immunology
|December 26, 2025
PubMed
概括

高编程细胞死亡-1 (PD-1) 表达在效应器记忆T细胞上预测胃癌患者对化疗免疫治疗的反应更好. 这一发现可能有助于确定那些将受益于PD-1阻断治疗的患者.